BRIEF — Scibase Says EIS Technology Primary Endpoint In NIH Study

Oct 15 (Reuters) — SciBase Holding AB (publ): Scibase's Electrical Impedance Spectroscopy (Eis) Technology Selected As Primary Endpoint In National Institute Of Health (Nih) Skin Barrier Study Source text:... Further company coverage: SCIB.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;)